Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery
Clinical and Translational Radiation Oncology · 2025-07 · 53 · 100967
DOI: 10.1016/j.ctro.2025.100967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Radiation Oncology, 2025-07. Verfasst von Dan-Qiong Wang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sci…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and purpose: This study aimed to compare the safety and efficacy of simultaneous integrated boost (SIB) and sequential boost (SeB) during hypofractionated WBI. Materials and methods: This study analyzed data from two prospective studies, including 1,132 patients with pT1-3 N0-3 M0 breast cancer, of whom 775 received SIB and 357 received SeB. The prescribed dose was 43.5 Gy in 15 fractions to whole breast and/or nodal region, with either 49.5 Gy in 15 fractions (SIB) or 8.7 Gy in 3 fractions (SeB) delivered to tumor bed. Outcomes analyzed included survival outcomes, treatment-related toxicities, and cosmetic outcomes.
Results
The 5-year outcomes were local control rates of 97.8 % vs. 98.8 % (p = 0.12), locoregional control rates of 97.7 % vs. 97.1 % (p = 0.72), disease-free survival of 94.1 % vs. 93.1 % (p = 0.71), overall survival of 97.4 % vs. 97.1 % (p = 0.88), and breast-specific survival of 98.2 % vs. 97.5 % (p = 0.43) for SIB versus SeB, respectively. After stabilized inverse probability of treatment weighting, differences between groups remained non-significant. Rates of fair or poor cosmetic outcomes before and after radiotherapy were lower in the SIB group, but there was no difference in cosmetic deterioration (9.8 % vs. 7.6 %, p = 0.22). Grade 2 or higher toxicities, including skin toxicity, pneumonitis, breast swelling, pain, induration, lymphedema, and shoulder mobility issues, were comparable between groups.
Conclusion
SIB is a viable alternative to SeB, offering comparable toxicity profiles and survival outcomes while shortening treatment duration. Longer follow-up is warranted to assess long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
- Department of Radiation Oncology, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
Zitieren
APA
Wang, D. Q., Song, Y. C., Jing, H., Fang, H., Song, Y. W., Liu, Y. P., Jin, J., Qi, S. N., Tang, Y., Lu, N. N., Chen, B., Li, N., Zhai, Y. R., Zhang, W. W., Liu, X., Chen, S. Y., Yang, Z. B., Sun, G. Y., Zhao, X. R., …, & Wang, S. L. (2025). Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery. Clinical and Translational Radiation Oncology, 53, 100967. https://doi.org/10.1016/j.ctro.2025.100967
Vancouver
Wang DQ, Song YC, Jing H, Fang H, Song YW, Liu YP, et al. Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery. Clinical and Translational Radiation Oncology. 2025;53:100967. doi:10.1016/j.ctro.2025.100967
BibTeX
@article{Wang2025,
author = {Wang, Dan-Qiong and Song, Yu-Chun and Jing, Hao and Fang, Hui and Song, Yong-Wen and Liu, Yue-Ping and Jin, Jing and Qi, Shu-Nan and Tang, Yuan and Lu, Ning-Ning and Chen, Bo and Li, Ning and Zhai, Yi-Rui and Zhang, Wen-Wen and Liu, Xin and Chen, Si-Ye and Yang, Zhuan-Bo and Sun, Guang-Yi and Zhao, Xu-Ran and Qiu, Zi-Han and Li, Ye-Xiong and Tang, Yu and Wang, Shu-Lian},
title = {Comparison of simultaneous integrated tumor bed boost and sequential boost during hypofractionated whole-breast irradiation after breast-conserving surgery},
journal = {Clinical and Translational Radiation Oncology},
year = {2025},
volume = {53},
pages = {100967},
doi = {10.1016/j.ctro.2025.100967}
}
EUVIMED